Bipolar disorders in DSM-5: Strengths, problems and perspectives

International Journal of Bipolar Disorders

Volumn 1, Issue 1, 2013, Pages 1-3

  Angst, Jules ^a  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; BIPOLAR DISORDER; DSM-5; HUMAN; HYPOMANIA; MAJOR DEPRESSION; MOOD CHANGE; PRIORITY JOURNAL; SYMPTOM ASSESSMENT;

EID: 84899567778     PISSN: None     EISSN: 21947511     Source Type: Journal    
DOI: 10.1186/2194-7511-1-12     Document Type: Article

References (16)

1. Angst J, Gamma A, Gerber-Werder R, Zarate CA Jr, Manji HK. Does long-term medication with lithium, clozapine or antidepressants prevent or attenuate dementia in bipolar and depressed patients? Int J Psychiatr Clin Pract. 2007; 11:2-8.
2. Angst J, Gamma A, Clarke D, Ajdacic-Gross V, Rössler W, Regier D. Subjective distress predicts treatment seeking for depression, bipolar, anxiety, panic, neurasthenia and insomnia severity spectra. Acta Psychiatr Scand. 2010; 122:488-498.
3. Angst J, Gamma A, Bowden CL, Azorin JM, Perugi G, Vieta E, Young AH Diagnostic criteria for bipolarity based on an international sample of 5,635 patients with DSM-IV major depressive episodes. Eur Arch Psychiatry Clin Neurosci. 2012; 262:3-11
4. Correa R, Akiskal H, Gilmer W, Nierenberg AA, Trivedi M, Zisook S. Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression? J Affect Disord 2012; 127:10-8
5. Da Silva J, Gonçalves-Pereira M, Xavier M, Mukaetova-Ladinska EB. Affective disorders and risk of developing dementia: systematic review. Br J Psychiatry 2013; 202:177-186.
6. Hantouche E, Azorin JM, Lancrenon S, Garay R-P, Angst J. Prévalence de l'hypomanie dans les dépressions majeures récurrentes ou résistantes: enquêtes Bipolact. Ann Med Psychol. 2009; 167:30-7
7. Kessing LV, Sondergard L, Forman JL, Andersen PK. Lithium treatment and risk of dementia. Arch Gen Psychiatry 2008; 65:1331-1335.
8. Merikangas KR, Cui L, Kattan G, Carlson G, Youngstrom EA, Angst J. Mania with and without depression in a community sample of U.S. adolescents. Arch Gen Psychiat. 2012; 69:943-951
9. Merikangas KR, Lihong C, Heaton L, Nakamura E, Roca C, Ding J, Qin H, Yao Y, Zarate CA, Angst J. Independence of familial transmission of mania and depression: results of the NIMH family study of affective spectrum disorders. Mol Psychiatry 2999. In press.
10. Moffitt TE, Caspi A, Taylor A, Kokaua J, Milne BJ, Polanczyk G, Poulton R. How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychol Med. 2010; 40:899-909.
11. Nunes PV, Forlenza OV, Gattaz WF. Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder. Br J Psychiatry. 2007; 190:359-360
12. Päären A, von Knorring A-L, Olsson G, Von Knorring L, Bohman H, Jonsson U Hypomania spectrum disorders from adolescence to adulthood: a 15-year follow-up of a community sample. J Affect Disord. 2013; 145:190-199
13. Phillips ML, Kupfer DJ. Bipolar disorder diagnosis: challenges and future directions. Lancet. 2013; 381:1663-1671
14. Post RM, Kalivas P. Bipolar disorder and substance misuse: pathological and therapeutic implications of their comorbidity and cross-sensitisation. Br J Psychiatry. 2013; 202:172-176.
15. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry. 1970; 126:983-7
16. Rybakowski JK, Angst J, Dudek D, Pawlowski T, Lojko D, Siwek M, Kiejna A. Polish version of the Hypomania Checklist (HCL-32) scale: the results in treatment-resistant depression. Eur Arch Psychiat Neurol Sci. 2010; 260:139-144.